Medicamentos OTC, Genéricos y de Marca - FARMACIA DEL NIÑO

~~$ 849.20~~ $ 679.36

MOTILIUM (DOMPERIDONA) 10 mg

Comparable a: Motilium
Sustancia activa: Domperidona
Concentración: 10 mg por tableta
Presentación: Caja con 30 tabletas
Laboratorio: JANSSEN-CILAG
Origen: México

Este medicamento se utiliza para el tratamiento de náuseas, vómitos y síntomas de motilidad gastrointestinal lenta (como sensación de llenura, distensión y malestar post-prandial). La domperidona actúa aumentando el movimiento del estómago y los intestinos, facilitando la digestión y reduciendo las náuseas.

El consumo de este producto es responsabilidad de quien lo recomienda y quien lo usa. Consulte a su médico antes de consumir cualquier medicamento.

THERAPEUTIC INDICATIONS: The dyspeptic symptom complex is often associated with delayed gastric emptying, gastroesophageal reflux esophagitis:

- Feeling at epigastric fullness, early satiety, feeling of abdominal distention, upper abdominal pain.

- Belching, flatulence.

- Nausea and vomiting.

- Heartburn with or without regurgitation of gastric contents into the mouth.

- Nausea and vomiting of functional origin, organic, infectious or dietetic or induced by radiation therapy or pharmacotherapy.

A specific indication is nausea and vomiting induced by dopamine agonists, such as those used in Parkinson's disease (such as L-dopa and bromocriptine).

CONTRAINDICATIONS: Motilium ® is contraindicated in the following situations:

Known hypersensitivity to domperidone or any of its excipients.

Prolactin-releasing pituitary tumor (prolactinoma).

Coadministration with oral ketoconazole, erythromycin, or other potent CYP3A4 inhibitors that prolong the QTc interval such as fluconazole, voriconazole, clarithromycin, amiodarone, and telithromycin.

Motilium ® should not be used in cases in which the stimulation of gastric motility might be dangerous, for example, gastrointestinal hemorrhage, mechanical obstruction or perforation.

CAUTIONS: When using antacids or antisecretory agents, concomitantly, they should be administered after meals and not before them, ie should not be administered simultaneously with the tablets and suspension Motilium ®.

Use Precautions: Enteric coated tablets contain lactose and may be unsuitable for patients with lactose intolerance, galactosemia, or malabsorption of glucose / galactose.

The oral suspension contains sorbitol and may be inadequate for patients intolerant to sorbitol.

Use in children: Because the metabolic and blood-brain barrier are not fully developed during the first months of life, Motilium ® as well as any medication that is administered to infants younger, should be used with caution and under close supervision care.

Since the typical absence of neurological side effects Motilium ® is due to the limited penetration through the blood brain barrier, the occurrence of these effects can not be totally excluded in babies under 1 year.

Use in hepatic impairment: Since domperidone is extensively metabolized in the liver, Motilium ® should be used with caution in patients with liver damage.

Use in renal impairment: In patients with severe renal insufficiency (serum creatinine> 6 mg/100 ml, for example,> 0.6 mmol / l) elimination half-life of domperidone is increased from 7.4 to 20.8 hours but plasma levels are lower than in healthy volunteers. Since a small amount of the drug is excreted by the kidneys, it is unlikely that the dose of a single acute dose needs to be adjusted in patients with renal failure. However, with repeated administration, frequency of administration should be reduced to once or twice daily depending on the severity of damage, and may also be necessary to reduce the dose.

Generally, patients with prolonged therapy should be reviewed regularly.

Effects on ability or use machines: Motilium ® does not affect mental alertness.

RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION:

Use in pregnancy: There are limited post-marketing data on the use of domperidone in pregnant women. A study in rats has shown reproductive toxicity at high doses, is toxic to the mother. No one knows the potential risk to humans. Therefore, Motilium ® should be used during pregnancy only where justified by the anticipated therapeutic benefit.

DOSAGE AND ADMINISTRATION:

Adults and adolescents (over 12 years and weighing 35 kg or more):

Tablets: 1 to 2 tablets of 10 mg three to four times a day, with a maximum daily dose of 80 mg.

CARNOTPRIM (METOCLOPRAMIDA) 10 MG 20 TAB

$ 377.17

CARNOTPRIM (METOCLOPRAMIDA) 10 mg

Comparable a: Carnotprim
Sustancia activa: Metoclopramida
Concentración: 10 mg por tableta
Presentación: Caja con 20 tabletas
Laboratorio: Carnot
Origen: México

Este medicamento se utiliza para el tratamiento de náuseas y vómitos de diversas causas, así como en el manejo de trastornos de la motilidad gastrointestinal, ya que la metoclopramida ayuda a acelerar el vaciado del estómago y favorece el movimiento intestinal.

El consumo de este producto es responsabilidad de quien lo recomienda y quien lo usa. Consulte a su médico antes de consumir cualquier medicamento.

THERAPEUTIC INDICATIONS: In gastroenterocinéticas properties, central and peripheral antiemetic and analgesic central CARNOTPRIM ® (metoclopramide) may be useful therapeutically and / or prophylaxis in the following disease entities:

Gastrointestinal Disorders: gastroesophageal reflux, infectious gastroenteritis, gastric ulcer, pyloric stenosis, chronic intestinal pseudo-primitive.

Iatrogenic gastroparesis: To counteract the effects of the use of anticholinergics, opiates, dopamine.

Surgical sequelae: Vagotomy with pyloroplasty fundic vagotomy, partial gastrectomy.

Psychic and neuromuscular disorders: Anorexia nervosa, amyloidosis, collagen diseases, scleroderma, muscular dystrophy (spastic colon), various neuropsychiatric syndromes.

Metabolic and endocrine disorders: diabetes, hypothyroidism, renal failure.

In acute or chronic vomiting, etiology, gastroenterology, infectious, metabolic, endocrine, neurological, iatrogenic, psychogenic, anatomical breathing.

Prophylactic utility nausea and / or vomiting from chemotherapy, radiotherapy, PeriAnesthesia, travel sickness, etc..

Useful for centrally acting analgesic (alone or in interaction): As an aid in vascular headaches (migraine).

Useful in the induction of lactation. Assistant when required to induce lactation.

Hypersensitivity to metoclopramide. Intestinal obstruction, perforation or any other condition in which increased gastrointestinal motility is risky. Acute appendicitis, extrapyramidal syndrome.

CAUTIONS: When administered metoclopramide in conjunction with psychotropic drugs, antihistamines, or barbiturates, it should be noted that additional depressive effect may occur in the CNS, also when alcohol is consumed concurrently with the drug.

When you use the injectors, if the medicine is applied quickly can even cause extrapyramidal symptoms (torticollis, trismus, oculogyric crisis), which are reversible after discontinuation of the drug or give in to the administration of diazepam or diphenhydramine. In the international literature, the emergence of extrapyramidal symptoms with metoclopramide at therapeutic doses is 1 in 33,000 patients.

In patients with chronic renal failure should be evaluated drug administration for prolonged periods, because their elimination is via the kidneys in 98% and, if necessary, adjust the dose of medication.

RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: Metoclopramide has been widely used during pregnancy to relieve both hyperemesis gravidarum, gastroesophageal reflux and gastroparesis that may occur during pregnancy.

The general consensus recommended during the second and third trimester of pregnancy, as with most of the drugs are not contraindicated during pregnancy, their prescription during the first quarter was the opinion of the treating physician taking into account the severity of the case, potential benefits and likely risks that might be for the product.

Metoclopramide is excreted in small amounts in breast milk

DOSAGE AND ADMINISTRATION: Oral.

CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, gastroesophageal reflux, anti-migraine).

Children 6 to 12 years: ½ tablet (5 mg) 3 times daily before meals.

Over 12 years or over 40 kg:
1 tablet 3 or 4 times daily before meals.

CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, anti-migraine, assist in the induction of lactation).

Adults and children over 40 kg: 1 tablet 3 or 4 times daily before meals.

Induction of lactation: 1 tablet every 8 hours, depending on the response of the patient, for a maximum period of 10 days.

TERRAMICINA POMADA OFTALMICA 10 G

~~$ 212.00~~ $ 199.91

GAAP (LATANOPROST) 0.005% 3 ML

~~$ 950.45~~ $ 888.66

ALPHAGAN (BRIMONIDINA) 0.02% SOL. OFT

~~$ 1,393.00~~ $ 1,302.45

TRILEPTAL (OXCARBAZEPINA) 50 GRAG 600 MG

$ 2,879.18

NEURONTIN (GABAPENTINA) 300 MG 30 CAPS

~~$ 1,479.84~~ $ 1,378.47

NEURONTIN (GABAPENTINA) 300 mg

Comparable a: Neurontin
Sustancia activa: Gabapentina
Concentración: 300 mg por cápsula
Presentación: Caja con 30 cápsulas
Laboratorio: PFIZER
Origen: México

Neurontin es un medicamento anticonvulsivo y neuromodulador utilizado para el tratamiento de epilepsia (como terapia adyuvante) y dolor neuropático (como neuropatía diabética o neuralgia posherpética). La gabapentina actúa modulando la actividad de los neurotransmisores en el sistema nervioso central para ayudar a reducir las convulsiones y aliviar el dolor de origen nervioso.

El consumo de este producto es responsabilidad de quien lo recomienda y quien lo usa. Consulte a su médico antes de consumir cualquier medicamento.

THERAPEUTIC INDICATIONS:

Anticonvulsant:

Epilepsy: Gabapentin is indicated as monotherapy for partial seizures, with or without secondary generalization in adults and children over 12 years.

Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with or without secondary generalization in adults and children over 3 years.

Neuropathic Pain: Gabapentin is indicated for the treatment of neuropathic pain in patients 18 years of age and older.

Contraindications Gabapentin is contraindicated in patients who have shown hypersensitivity to gabapentin or ingredients.

CAUTIONS:

General: Although there is no evidence of rebound seizures with gabapentin, the sudden interruption in the administration of anticonvulsant drugs in epileptic patients may cause status epilepticus (see DOSAGE AND ADMINISTRATION.)

In general, gabapentin is not considered to be useful for the treatment of absence seizures.

Patients who received concomitant treatment with morphine may experience increases in the concentration of gabapentin. Patients should be watched carefully because of signs of central nervous system depression, drowsiness, and the dose of gabapentin or morphine should be reduced appropriately.

Effects on ability to drive motor vehicles or use machines Patients should be advised not to drive or use potentially dangerous machinery until you know if this medication does not affect your ability to perform these activities.

RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION:

Pregnancy: There have been no adequate and well controlled studies in pregnant women. Therefore, this drug should only be used during pregnancy if the potential benefit to the patient justifies the potential risk to the fetus (see PRECAUTIONS in relation to terms of carcinogenicity, mutagenicity, teratogenicity and fertility, teratogenesis).

Breast-feeding: Gabapentin is excreted in human milk. Due to the unknown effect on the infant, caution should be exercised when gabapentin is administered to mothers during lactation. Gabapentin should only be used in nursing mothers when the benefits to the mother clearly outweigh the risks to the child.

DOSAGE AND ADMINISTRATION: BAPEX is administered orally, with or without food. Thetitration is based on clinical response and plasma concentrations.

Adults and adolescents (> 12 years of age) with epilepsy: Start with 300 mg three times daily(900 mg) from the first day or 300 mg starting with the 1st. day, 600 mg the 2nd. day andending with 900 mg the third day. The dose may be increased gradually according to clinical response. The maximum interval between doses should not exceed 12 hours.

BAPEX dose in pediatric patients 3 to 12 years, will be initially 10 to 15 mg / kg / day inequally divided doses (three times a day).

The effective dose in pediatric patients aged 5 years and older after three days of graduationis 25 to 35 mg / kg / day in equally divided doses (three times a day) and patients 3 to 5 years is 40 mg / kg / day in equally divided doses (three times a day).

For adult patients with neuropathic pain, start with 900 mg / day in three doses. Adjust the dose according to response, not to exceed 3.600 mg / day.